Trial of Artesunate Combination Therapy in Pakistan

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This study is an evaluation of the benefit of adding artesunate to existing first and second line antimalarial therapies in Pakistan. A placebo controlled trial was carried out to assess two potential benefits of Artesunate Combination Therapy (ACT): efficacy and potential for transmission reduction.
Epistemonikos ID: 0b7c4b88960afa5e49a09b9fcd104407ceb202ca
First added on: May 05, 2024